To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·08-19 07:13
      ARKG Investment Tracker position change: Decreased position in 10x Genomics, Inc. by 361 shares, the number of shares held decreased 0.012% compared to the previous period and now represents 9.95% of the total position.
      312Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-19 07:13
      ARKG Investment Tracker position change: Increased position in Schrodinger Inc. by 4,717 shares, the number of shares held increased 0.22% compared to the previous period and now represents 2.22% of the total position.
      38Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-16
      ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 65,860 shares, the number of shares held increased 0.64% compared to the previous period and now represents 0.69% of the total position.
      12.42K2
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-16
      ARKG Investment Tracker position change: Increased position in Natera by 1,485 shares, the number of shares held increased 0.64% compared to the previous period and now represents 4.22% of the total position.
      201Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-16
      ARKG Investment Tracker position change: Increased position in Butterfly Network Inc by 29,555 shares, the number of shares held increased 0.64% compared to the previous period and now represents 2.39% of the total position.
      357Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-16
      ARKG Investment Tracker position change: Increased position in COMPASS Pathways plc by 27,655 shares, the number of shares held increased 0.64% compared to the previous period and now represents 3.35% of the total position.
      135Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-16
      ARKG Investment Tracker position change: Increased position in Beam Therapeutics, Inc. by 14,280 shares, the number of shares held increased 0.64% compared to the previous period and now represents 3.46% of the total position.
      214Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-16
      ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 84,500 shares, the number of shares held increased 0.64% compared to the previous period and now represents 2.55% of the total position.
      2.72K2
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-16
      ARKG Investment Tracker position change: Increased position in Illumina by 2,225 shares, the number of shares held increased 0.64% compared to the previous period and now represents 3.92% of the total position.
      48Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-16
      ARKG Investment Tracker position change: Increased position in Prime Medicine, Inc. by 46,550 shares, the number of shares held increased 0.64% compared to the previous period and now represents 1.35% of the total position.
      124Comment
      Report
    • empty
      No following yet
       
       
       
       

      Most Discussed